Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02109770 · ClinicalTrials.gov registry record
Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNA
A clinical trial, sponsored by Natera.
- Completed
- Registry status
- 216
- Enrollment target
NCT02109770: Completed study, sponsored by Natera.
NCT02109770 is a clinical trial that has completed, run by Natera. The registered enrollment target is 216 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02109770 has completed, sponsored by Natera.
- COMPLETED
- Registry status
- 216 participants
- Enrollment target
Study Summary
The purpose of this study is to collect blood from families with a child who has been diagnosed with a chromosomal disorder including microdeletions in order to further develop a non-invasive prenatal screening test based on fetal DNA isolated from maternal blood.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 216 participants |
| Start Date | 2012-10 |
| Est. Completion | 2019-08 |
What the finished NCT02109770 record still lists
NCT02109770 is an observational study that tracks outcomes without assigning an intervention. The registered 216 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02109770 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02109770 about?
NCT02109770 is a clinical study titled "Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNA". The purpose of this study is to collect blood from families with a child who has been diagnosed with a chromosomal disorder including microdeletions in order to further develop a non-invasive prenatal screening test based on fetal DNA isolated from maternal blood.
What is the current status of trial NCT02109770?
This trial is currently completed. The enrollment target is 216 participants. The study started on 2012-10. Estimated completion is 2019-08.
Who is sponsoring clinical trial NCT02109770?
This trial is sponsored by Natera, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02609685 · 216 participants · NA
Active Surveillance of Papillary Thyroid Microcarcinoma
- NCT04994873 · 216 participants · NA
Skills to Enhance Positivity in Suicidal Youth
- NCT05264779 · 216 participants · NA
The Periviable GOALS Decision Support Tool
- NCT05434130 · 216 participants · Phase 2
Modulating Exercise Dosage to Improve Concussion Recovery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia